共 58 条
[1]
Belchetz P.E., Drug therapy: Hormonal treatment of postmenopausal women, N Engl J Med, 330, pp. 1062-1171, (1994)
[2]
Stampfer M.J., Colditz G.A., Willett W.C., Et al., Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study, N Engl J Med, 325, pp. 756-762, (1991)
[3]
Grodstein F., Stampfer M.J., Manson J.E., Et al., Postmenopausal estrogen and progestin use and the risk of cardiovascular disease, N Engl J Med, 335, pp. 453-461, (1996)
[4]
Hulley S., Grady D., Bush T., Et al., Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women, JAMA, 280, pp. 605-651, (1998)
[5]
Beeson P.B., Age and sex associations of 40 autoimmune diseases, JAMA, 96, pp. 457-462, (1994)
[6]
Sanchez-Guerrero J., Liang M.H., Karlson E.W., Et al., Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus, Ann Intern Med, 122, pp. 430-432, (1995)
[7]
Ahmed S.A., Pendhale W.J., Talal N., Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action, Am J Pathol, 121, pp. 531-551, (1985)
[8]
Kanda N., Tsuchida T., Tamaki K., Estrogen enhancement of anti-double stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus, Arthritis Rheum, 42, pp. 328-337, (1999)
[9]
Cid M.C., Kleinman H.K., Grant D.S., Et al., Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1 and vascular cell adhesion molecule type 1, J Clin Invest, 93, pp. 17-25, (1994)
[10]
Nabulsi A.A., Folsom A.R., White A., Et al., Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women, N Engl J Med, 328, pp. 1069-1075, (1993)